Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease - Zheng,L.; Nukuna,B.; Brennan,M.L.; Sun,M.; Goormastic,M.; Settle,M. (J Clin Invest, 2004)